Peptidylarginine deiminase 4 deficiency alleviates hypoxia/reoxygenation-induced cardiomyocyte injury
PLOS One · 2025
DOI: 10.1371/journal.pone.0330864 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Matthias Mand und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Myocardial Reperfusion Injury, Hydrolases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medizinische Fakultät, Universität zu Köln.
Abstract (Originalsprache)
Background
Cardiac ischemia reperfusion (I/R) injury is a serious consequence of reperfusion therapy for myocardial infarction (MI). Peptidylarginine deiminase 4 (PAD4) is a calcium-dependent enzyme that catalyzes the citrullination of proteins. In previous studies, PAD4 inhibition protected distinct organs from I/R injury by preventing the formation of neutrophil extracellular traps (NETs) and attenuating inflammatory responses. Here, we hypothesized that cardiomyocyte PAD4 expression may play a role in acute I/R injury.
Methods
Infarct size was determined in isolated pressure constant-perfused hearts from WT and PAD4-deficient (PAD4 -/- ) mice. Additionally, extracellular reactive oxygen species (ROS) and cell viability were quantified in freshly isolated adult cardiomyocytes exposed to hypoxia followed by reoxygenation (H/R). Resistance to oxidative stress was proven in both genotypes by treatment of neonatal cardiomyocytes with hydrogen peroxide. Moreover, intracellular ROS formation, ATP production, mitochondrial membrane polarisation, caspase-3 activation, and cell viability were quantified after hypoxia followed by 4 h and 20 h of reoxygenation, respectively. The PAD4-specific inhibitor GSK484 was added before H/R or at reperfusion in certain experiments.
Results
Infarct size was smaller in PAD4 -/- hearts following I/R when compared to the WT. Similarly, the viability of adult and neonatal PAD4 -/- cardiomyocytes was better preserved after H/R, accompanied by reduced ROS formation. PAD4 deficiency maintained mitochondrial integrity and protected neonatal cardiomyocytes against apoptosis. However, these cells did not exhibit resistance to hydrogen peroxide-induced cell death, indicating an unaltered antioxidative state. Whereas pharmacological PAD4 inhibition by GSK484 before H/R sustained intracellular ATP levels in WT cardiomyocytes, administration of GSK484 at reoxygenation did not. However, GSK484 significantly improved cardiomyocyte metabolic activity, regardless of the time of administration.
Conclusions
Our study is the first to demonstrate that PAD4 expression in cardiomyocytes contributes to H/R injury independent of systemic immune responses and NETs. Consequently, PAD4 may serve as a therapeutic target to alleviate I/R injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cardiac Surgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
- Cardioprotection Unit, Institute for Pathophysiology, West German Heart and Vascular Center, University of Essen Medical School, University of Duisburg-Essen, Essen, Germany.
ORCID-Profile: Petra Kleinbongard, Thorsten Wahlers, Adnana Paunel-Görgülü
Förderung
- Medizinische Fakultät, Universität zu Köln
Zitieren
APA
Mand, M., Holthaus, M., Lieder, H. R., Kleinbongard, P., Conradi, L., Wahlers, T., & Paunel-Görgülü, A. (2025). Peptidylarginine deiminase 4 deficiency alleviates hypoxia/reoxygenation-induced cardiomyocyte injury. PLOS One. https://doi.org/10.1371/journal.pone.0330864
Vancouver
Mand M, Holthaus M, Lieder HR, Kleinbongard P, Conradi L, Wahlers T, et al. Peptidylarginine deiminase 4 deficiency alleviates hypoxia/reoxygenation-induced cardiomyocyte injury. PLOS One. 2025. doi:10.1371/journal.pone.0330864
BibTeX
@article{Mand2025,
author = {Mand, Matthias and Holthaus, Michelle and Lieder, Helmut R and Kleinbongard, Petra and Conradi, Lenard and Wahlers, Thorsten and Paunel-Görgülü, Adnana},
title = {Peptidylarginine deiminase 4 deficiency alleviates hypoxia/reoxygenation-induced cardiomyocyte injury},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0330864}
}
EUVIMED